Related Experiment Video
Updated: Feb 7, 2026

Analysis of mRNA Nuclear Export Kinetics in Mammalian Cells by Microinjection
Published on: December 4, 2010
SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes
Lan Fang1, Hongqi Teng1, Yilin Wang2
1Shanghai Tenth People's Hospital of Tongji University, School of Medicine and School of Life Science and Technology, Tongji University, Shanghai 200072, China.
Abstract:
YAP, a key effector of Hippo pathway, is activated by its translocation from cytoplasm to nucleus to regulate gene expression and promote tumorigenesis. Although the mechanism by which YAP is suppressed in cytoplasm has been well-studied, how the activated YAP is sequestered in the nucleus remains unknown. Here, we demonstrate that YAP is a nucleocytoplasmic shuttling protein and its nuclear export is controlled by SET1A-mediated mono-methylation of YAP at K342, which disrupts the binding of YAP to CRM1. YAP mimetic methylation knockin mice are more susceptible to colorectal tumorigenesis. Clinically, YAP K342 methylation is reversely correlated with cancer survival. Collectively, our study identifies SET1A-mediated mono-methylation at K342 as an essential regulatory mechanism for regulating YAP activity and tumorigenesis.
Insights
The Yes-associated protein (YAP) nuclear export is regulated by SET1A-mediated mono-methylation at K342, disrupting CRM1 binding. This finding reveals a novel mechanism controlling YAP activity and tumorigenesis.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- The Yes-associated protein (YAP) is a crucial regulator of gene expression and a key effector of the Hippo pathway.
- YAP activation involves translocation from the cytoplasm to the nucleus, promoting tumorigenesis.
- While YAP's cytoplasmic suppression is understood, its nuclear sequestration mechanisms remain unclear.
Purpose of the Study:
- To investigate the regulatory mechanisms controlling activated YAP's nuclear localization.
- To identify the factors and modifications responsible for YAP nuclear export control.
- To explore the role of YAP regulation in colorectal tumorigenesis and cancer survival.
Main Methods:
- Investigated YAP as a nucleocytoplasmic shuttling protein.
- Identified SET1A-mediated mono-methylation at K342 as a regulator of YAP nuclear export.
- Analyzed the disruption of YAP-CRM1 binding by K342 methylation.
- Utilized YAP mimetic methylation knockin mice models.
- Correlated YAP K342 methylation levels with clinical cancer survival data.
Main Results:
- YAP undergoes nucleocytoplasmic shuttling, with nuclear export controlled by SET1A-mediated mono-methylation at K342.
- This specific methylation disrupts the interaction between YAP and CRM1, a key export receptor.
- YAP mimetic methylation knockin mice exhibited increased susceptibility to colorectal tumorigenesis.
- Clinical analysis revealed a reverse correlation between YAP K342 methylation and patient survival in cancer.
Conclusions:
- SET1A-mediated mono-methylation at K342 is a critical regulatory mechanism for YAP nuclear export.
- This epigenetic modification plays a significant role in controlling YAP activity and its contribution to tumorigenesis.
- YAP K342 methylation serves as a potential prognostic biomarker for cancer survival.
Related Concept Videos
Nuclear Export of mRNA
Nuclear Export of mRNA
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Export of Mitochondrial and Chloroplast Genes
Regulation of Nuclear Protein Sorting
Regulated mRNA Transport

